Trevor Klee’s Newsletter

Home
Archive
About
Is longevity a choice? How about obesity?
Examining the weirdly universal phenomena of obese, eyeless, long-lived cavedwellers
 • 
Trevor Klee
1
The way scientists think about obesity now is wrong.
Here's my tentative attempt at a better way of thinking about obesity.
 • 
Trevor Klee
3
GLP-1 and GIP agonism and antagonism is weird
And I don't entirely know what to make of it
 • 
Trevor Klee

March 2024

The twin mysteries of GLP-1 receptor agonists
A.k.a. what's the deal with Mounjaro?
 • 
Trevor Klee
7

February 2024

Viking Therapeutics has an $8 billion market cap with 27 full time employees. This is their story.
The lucrative, risky business of developing other people's molecules
 • 
Trevor Klee
When your family becomes inverse strangers
There’s a graph I saw a while ago on the Internet that’s stuck with me. It shows how you spend your time with others as you get older. So, from ages…
 • 
Trevor Klee
1
Karuna Therapeutics, a drug repurposing effort, sold for about $14 billion. This is their story.
How to turn $100k into $14 billion with just 16 years of regulatory slog and a few hundred million in investment
 • 
Trevor Klee

January 2024

5 Whys of Diabetes
My first published piece in Asimov Press!
 • 
Trevor Klee
1
How to get causation from correlation in genetics
A brief introduction to Mendelian randomization
 • 
Trevor Klee
2
Let's be more sincere in the New Year
Marvel, meet Sartre. Sartre, Marvel.
 • 
Trevor Klee
4

December 2023

© 2024 Trevor Klee
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture